Has Daniel Yanes received payments from drug or device companies?

Yes. Drug and device makers reported $43,797 in general payments to Daniel Yanes across 173 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Yanes did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Yanes come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Yanes

Dermatology · Washington, DCNPI 1306387584

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,825 of the $43,797 with a category attached, or 84.1%. Merz North America, Inc. accounts for 91.4% of it on its own, with 23 other manufacturers making up the rest.

$43,797in general payments, 2019–2025

Across 173 payments — averaging $253.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$40K
AbbVie$1K
Amgen$362
Johnson & Johnson$359
Incyte Corporation$354
Galderma Laboratories, L.p.$264
plus $1K from 18 others

What the payments were for

Consulting fees$36,82584%
Travel & lodging$1,4493%
Food & beverage$5,52313%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	31	$40,043
AbbVie	37	$1,242
Amgen	17	$362
Johnson & Johnson	12	$359
Incyte Corporation	14	$354
Galderma Laboratories, L.p.	12	$264
Sun Pharmaceutical Industries Inc.	8	$180
Lilly USA, LLC	6	$166
Boehringer Ingelheim	4	$115
Pfizer	5	$98
Sanofi	4	$81
Genentech USA, Inc.	3	$79
Arcutis Biotherapeutics, Inc.	3	$71
Journey Medical Corporation	2	$52
Revance Therapeutics, Inc.	2	$46
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$42
Biofrontera Inc.	2	$41
Almirall LLC	2	$39
Solta Medical, A Division Of Bausch Health US, LLC	2	$36
LEO Pharma Inc.	1	$35
Mayne Pharma Commercial LLC	1	$26
Organon	1	$26
Regeneron Healthcare Solutions, Inc.	1	$22
Sanofi-aventis U.S. LLC	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$482
Rinvoq$344
Tremfya$118

How this compares

$43,797 in reported general payments places this provider in the 80th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	21	$736
Ketoconazole	25	$329
Triamcinolone Acetonide	19	$234

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

Jonathan SilverbergWashington$4.5M
Adam FriedmanWashington$2.2M
Terrence KeaneyWashington$1.1M
Candrice HeathWashington$168K
Agnes ChangWashington$109K
Todd PerkinsWashington$102K
Karl SaardiWashington$101K
Noelle SherberWashington$96K
Yolanda HolmesWashington$80K
Cheri FreyWashington$79K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →